These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2589230)

  • 1. Combination chemotherapy with cytosine arabinoside (Ara-C) and cis-diamminedichloroplatinum (CDDP) for squamous cancers of the upper aerodigestive tract.
    Margolin K; Doroshow J; Leong L; Akman S; Carr BI; Odujinrin O; Flanagan B
    Am J Clin Oncol; 1989 Dec; 12(6):494-7. PubMed ID: 2589230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II trial of high-dose cytosine arabinoside and cisplatin in recurrent squamous carcinoma of the head and neck. A Piedmont Oncology Association Study.
    Powell BL; Craig JB; Muss HB; Zekan PJ; Cooper MR; Schnell FM; Hampton JW; White DR; Smith LR; Capizzi RL
    Am J Clin Oncol; 1988 Oct; 11(5):550-2. PubMed ID: 3177257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin and infusional cytosine arabinoside for the treatment of colorectal adenocarcinoma: a phase II trial.
    Tetef M; Leong L; Ahn C; Akman S; Chow W; Margolin K; Morgan RJ; Raschko J; Shibata S; Somlo G; Doroshow JH
    Cancer Invest; 1999; 17(2):114-7. PubMed ID: 10071595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sequential combination chemotherapy consisting of vincristine, peplomycin, methotrexate, cis-diamminedichloroplatinum (II), cytosine arabinoside and 5-fluorouracil, for advanced urothelial cancer].
    Yamauchi T; Hida S; Ooishi K; Okada K; Yoshida O
    Hinyokika Kiyo; 1985 Jul; 31(7):1093-104. PubMed ID: 2414981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus.
    Ilson DH; Ajani J; Bhalla K; Forastiere A; Huang Y; Patel P; Martin L; Donegan J; Pazdur R; Reed C; Kelsen DP
    J Clin Oncol; 1998 May; 16(5):1826-34. PubMed ID: 9586897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase II study of cisplatin and continuous infusion of vindesine in metastatic head and neck squamous cell cancer.
    Tellez-Bernal E; Recondo G; Guillot T; Benhamed M; Domenge C; Izzo J; Cvitkovic E; Armand JP
    Cancer; 1990 Aug; 66(4):640-4. PubMed ID: 2386892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II trial of cis-diamminedichloroplatinum (cis-platinum), vincristine, and peplomycin for advanced squamous cell carcinoma.
    Tamura K; Araki Y; Tateyama H; Maeda M; Seita M
    J Surg Oncol; 1987 Aug; 35(4):241-4. PubMed ID: 2441207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase II study of cisplatin and cytosine arabinoside for recurrent squamous cell carcinoma of the head and neck.
    Bernstein JI; Jacobs C; Meyers F; Rich-Goffinet L; Tanaka L
    Am J Clin Oncol; 1986 Feb; 9(1):58-60. PubMed ID: 3953492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cisplatin, raltitrexed, levofolinic acid and 5-fluorouracil in locally advanced or metastatic squamous cell carcinoma of the head and neck: a phase II randomized study.
    Caponigro F; Rosati G; De Rosa P; Avallone A; De Rosa V; De Lucia L; Comella P; Comella G
    Oncology; 2002; 63(3):232-8. PubMed ID: 12381902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II clinical trial of the combination VP-16, bleomycin, and cis-diamminedichloroplatinum in patients with advanced upper aerodigestive squamous cell carcinoma.
    Creagan ET; Chang M; Long HJ; Rubin J
    Head Neck Surg; 1987; 9(4):223-6. PubMed ID: 2444566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase II trial of cisplatin, methotrexate, levofolinic acid, and 5-fluorouracil in the treatment of patients with locally advanced, metastatic squamous cell carcinoma of the head and neck.
    Caponigro F; Comella P; Marcolin P; Russo Spena F; Biglietto M; Cartenì G; De Lucia L; Avallone A; Gravina A; Comella G
    Cancer; 1999 Feb; 85(4):952-9. PubMed ID: 10091775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cisplatin plus cytosine arabinoside in the treatment of squamous cell carcinoma of the head and neck.
    Stewart DJ; Maroun JA; Laframboise G; Gerin-Lajoie J
    Am J Clin Oncol; 1986 Jun; 9(3):200-3. PubMed ID: 3728372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vinorelbine, cisplatin, and 5-fluorouracil as initial treatment for previously untreated, unresectable squamous cell carcinoma of the head and neck: results of a phase II multicenter study.
    Gebbia V; Mantovani G; Farris A; Agostara B; Desogus A; Curreli L; Moschella F; Di Gregorio C; Bajetta E; Gebbia N
    Cancer; 1997 Apr; 79(7):1394-400. PubMed ID: 9083162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ifosfamide, cisplatin, and 13-Cis retinoic acid for patients with advanced or recurrent squamous cell carcinoma of the head and neck: a phase I-II study.
    Recchia F; Lalli A; Lombardo M; De Filippis S; Saggio G; Fabbri F; Rosselli M; Capomolla E; Rea S
    Cancer; 2001 Aug; 92(4):814-21. PubMed ID: 11550152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I study of high-dose cytosine arabinoside and etoposide in patients with advanced malignancies.
    Powell BL; Muss HB; Capizzi RL; Caponera ME; White DR; Zekan PJ; Atkins JN; Jackson DV; Richards F; Craig JB
    Cancer Chemother Pharmacol; 1987; 19(3):250-2. PubMed ID: 3581419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisplatin, cytosine arabinoside, and pentoxifylline in the treatment of squamous cell carcinoma of the head and neck.
    Stewart DJ; Cripps MC; Fingert H; Lamothe A; Laframboise G; Gerin-Lajoie J
    Am J Clin Oncol; 1993 Apr; 16(2):123-6. PubMed ID: 8452103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combination chemotherapy with 5-FU and CDDP or CDDP analog for head and neck cancer].
    Fujii M; Ohno Y; Tokumaru Y; Imanishi Y; Kanke M
    Gan To Kagaku Ryoho; 1996 Nov; 23(13):1740-6. PubMed ID: 8937483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of cisplatin antitumor activity by short infusional high-dose cytosine arabinoside in advanced pretreated head and neck carcinoma: a phase II study.
    Jelic S; Mitrovic L; Kovcin V; Nikolic-Tomasevic Z; Radulovic S; Tomasevic Z; Popov I
    J Chemother; 1996 Aug; 8(4):304-9. PubMed ID: 8873838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salvage chemotherapy with PEM and long-CF regimen in CDDP refractory advanced head and neck cancer.
    Kohno N; Ichikawa G; Shirasaka T; Inuyama Y; Kawaida M; Ohnuma T
    Gan To Kagaku Ryoho; 1995 Aug; 22 Suppl 3():209-14. PubMed ID: 7661582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-Fluorouracil, leucovorin, hydroxyurea, and escalating doses of continuous-infusion cisplatin with concomitant radiotherapy: a clinical and pharmacologic study.
    Vokes EE; Moormeier JA; Ratain MJ; Egorin MJ; Haraf DJ; Mick R; Weichselbaum RR
    Cancer Chemother Pharmacol; 1992; 29(3):178-84. PubMed ID: 1733549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.